Results and Discussion
To determine whether KLHL12 plays a role in apoB100-VLDL trafficking and secretion, we first asked whether manipulating KLHL12 expression impacted apoB100 levels and the secretion of mature VLDL particles. KLHL12 in McA cells was depleted by transfecting cells with a KLHL12-specific small interfering RNA, and the levels of secreted and intracellular apoB100 were measured under steady-state radiolabeling conditions. A significant reduction of KLHL12 expression (confirmed by quantitative polymerase chain reaction and by Western blotting; Figures I and II in the online-only Data Supplement, respectively) in the presence of oleic acid/BSA complexes resulted in >50% decreases in the levels of secreted and intracellular apoB100 ( Figure 1A and 1B) . The effect of KLHL12 knockdown was specific to apoB100 because secretion of the constitutive hepatic protein albumin was unaltered ( Figure III in the onlineonly Data Supplement). This result provides further support that KLHL12 facilitates the transport of atypical, large COPII cargo. Data from density gradient fractionation showed that knockdown of KLHL12 had a profound effect on the secretion of the most lipidated species of apoB100, namely VLDL1 ( Figure 1C ). To further support a role of KLHL12 during the ER-to-Golgi trafficking of apoB100-VLDL, apoB100 levels were measured in ER microsomes and Golgi membranes isolated from KLHL12 silenced McA cells. The ratio of apoB100 recovery from ER to that from the Golgi apparatus increased by 60% in KLHL12-depleted cells compared with that of the controls ( Figure 1D ; the ER and Golgi markers distributions are shown in the Figure IV in the online-only Data Supplement). This shift suggested a decrease in VLDL vesicular transport and a concomitant accumulation in the ER. Overall, then, the collective data strongly imply that the trafficking of apoB100 from the ER to Golgi, where VLDL fully matures, [11] [12] [13] was compromised when KLHL12 expression was reduced.
Opposite results were seen in McA cells overexpressing KLHL12 ( Figure 1E and 1F; the overexpression was confirmed by Western blotting as shown in the Figure V in the online-only Data Supplement). In this case, the levels of secreted apoB100 were markedly increased, and there was a concomitant increase in the population of secreted VLDL1 ( Figure VI in the online-only McA cells were transfected with control or KLHL12-specific small interfering RNA (siRNA). Forty-eight hours later, the cells were incubated with 0.6 mmol/L OA/BSA complex for 1 hour, and the incubation was continued for an additional 3 hours with 35 S-methionine and cysteine ( 35 S-met/cys) added to radiolabel apoB100 to steady state. Secreted (A) and intracellular (B) recoveries of radiolabeled apoB100 in the conditioned media and cell lysates were normalized against total trichloracetic acid (TCA)-precipitated counts and total protein amounts. C, Density gradient analysis of secreted apoB100-associated lipoproteins. D, McA cells were treated as in A and B. Cell homogenates were separated by sucrose density gradient centrifugation to obtain endoplasmic reticulum (ER) microsomes and Golgi membranes, from which apoB100 was immunoprecipitated and quantified. The ER:Golgi ratio of apoB100 recovery was calculated and is displayed. E and F, McA cells were transfected with either Flag-tagged pcDNA3.1-KLHL12 or empty pcDNA3.1 vector (as a control) for 48 hours. Cells were then incubated with 0.6 mmol/L OA/BSA complex for 1 hour, and the incubation was continued for an additional 3 hours with 35 S-met/cys to radiolabel apoB100 to steady state. Secreted (D) and intracellular (E) recoveries of radiolabeled apoB100 in the conditioned media and cell lysates were normalized against total TCA-precipitated counts and total protein amounts. Although the focus of this report is on apoB100 (the sole form produced by human liver), rodent hepatic cells also produce apoB48. Limited analyses of the effects of KLHL12 knockdown and overexpression on apoB48 were also performed. On KLHL12 knockdown, there was also decreased recovery of apoB48, but to a lesser degree than for apoB100; in addition, there were minimal effects when KLHL12 was overexpressed ( Figure VIII in the online-only Data Supplement). These results most likely reflect the smaller proportion of apoB48 (approximately one third that of apoB100) that can be assembled into VLDL (eg, Fisher et al 14 ) , which would be expected to decrease the reliance on KLHL12 for the ER export of apoB48-containing lipoproteins.
In the experiments presented above, the McA cells were incubated with oleic acid/BSA complexes. This treatment augments apoB100 lipidation and secretion but has no effect on the preferential association of apoB100 with VLDL particles. In the absence of exogenous fatty acids, the low level of endogenous lipid synthesis can result in an increase in the amount of apoB100 destroyed by the ER-associated degradation pathway, but of the surviving molecules, most would be secreted in association with VLDL (reviewed in Brodsky and Fisher 15 and Ginsberg and Fisher 16 ). Under these conditions, KLHL12 again modulated apoB100 secretion (Figure 2A and 2B) because the amount of apoB100 decreased on KLHL12 knockdown (primarily in the VLDL density fractions; data not shown) and increased on KLHL12 overexpression ( Figure IX in the online-only Data Supplement).
Our laboratory and others have shown that apoB100 can be degraded by either the proteasome-mediated ER-associated degradation or by autophagy after ER exit (reviewed in Brodsky and Fisher 15 ). To define the fate of apoB100 after KLHL12 knockdown, we first focused on the role of autophagy, given that it is highly unlikely that an assembled apoB100-VLDL particle could retro-translocate from the ER lumen and gain S-methionine and cysteine for 3 hours to radiolabel apoB100 to steady state. Secreted (A) and intracellular (B) levels of radiolabeled apoB100 were decreased similar to that observed in Figure 1 . C, McA cells were radiolabeled to steady state, and the incubation with the autophagy inhibitor 3-methyl adenine (3-MA) increased intracellular apoB100 recovery in KLHL12 siRNA-treated cells. D, Confocal indirect immunofluorescence images from McA cells probed with antibodies to apoB100 (red), coat complex II (COPII; red), or albumin (red), or KLHL12 (green) as indicated. Arrows in the insets indicate colocalization (yellow) of apoB100, COPII, or albumin with KLHL12. Nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI; magnification, ×63). The inset is a ×10 zoom of the area of interest. E, Quantification of KLHL12 colocalization with either albumin or apoB100. A to C, Shown are the means, ±SEM, n=3. *P<0.05 and **P<0.01. D, Shown are the results representative of 3 independent experiments. E, Same as A to C, but n≥10 cells analyzed for each protein.
access to the cytoplasmic proteasome, which must occur in ER-associated degradation. In contrast, autophagy is known to collect and destroy large substrates, even those that reside within cellular organelles (reviewed in Yang and Klionsky 17 ). Consistent with this hypothesis, the autophagy inhibitor, 3-methyladenine, significantly increased the level of intracellular apoB100 in KLHL12 knockdown cells ( Figure 2C ).
Finally, we asked whether KLHL12 colocalizes with apoB100, which would provide additional support that this factor facilitates apoB100-VLDL secretion. By using a monoclonal antibody specific for rat apoB100, we observed that KLHL12 colocalized ≈8× more (P<0.01) with apoB100 than with albumin and that KLHL12 colocalized with COPII-positive vesicles ( Figure 2D and 2E) . Furthermore, the data also verified KLH12 association with the ER and not with the Golgi ( Figure  X in the online-only Data Supplement). These colocalizations of KLHL12 are consistent with the subcellular distribution previously reported in the procollagen studies. 7 In summary, our data demonstrate for the first time that KLHL12 plays a crucial role in delivering apoB100-VLDL particles to the Golgi apparatus for further maturation, an event that ultimately leads to the secretion of mature VLDL. Furthermore, KLHL12 appears to be a limiting factor that acts during ER-to-Golgi trafficking, at least in McA cells, because either increasing or decreasing KLHL12 levels had a significant effect on apoB100-VLDL secretion. We also find that autophagy is most likely responsible for the degradation of apoB100containing particles that escape ER-associated degradation but do not progress to the Golgi. The atypical physical properties of the ER-derived secretory vesicles we previously described 1 may have reflected not only a difference in physical structure relative to those vesicles carrying smaller cargo, but also the presence of additional proteins needed to form them, such as KLHL12 (this study) and others. 2, 18 Our next goal is to confirm the function of KLHL12 in vivo and to determine the molecular mechanism and relationships among KLHL12 and other factors required for apoB100-VLDL assembly and trafficking.
